This training focuses on the appropriate use of anticholinergic medications in psychiatric populations, covering both therapeutic applications and associated risks. Participants will learn to identify medications with high anticholinergic burden, manage common and severe adverse reactions (e.g., constipation, delirium), and implement strategies to minimize risks. The session includes case-based discussions on optimizing treatment while reducing anticholinergic side effects, particularly in patients taking antipsychotics like clozapine. Key takeaways include alternative approaches to managing extrapyramidal symptoms (EPS) and the importance of monitoring for complications such as ileus. The training aims to enhance clinical decision-making for safer, more effective patient care.
Credit & MOC Details
Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.
Credit types
MOC types
FDA REMS
Qualifies for MIPS
Target Specialties
Address:
- 800 Maine Avenue SW
Pricing
100% of listed courses are free
25 of 25 courses listed here are free.
Collected from the provider’s public pages · source
Specialties served/covered
- Addiction Medicine
- Addiction Psychiatry
- Child & Adolescent Psychiatry
- Clinician Wellness & Burnout
- General & Adult Psychiatry
- Geriatric Psychiatry
- Maternal-Fetal Medicine
- Mood & Anxiety Disorders
- Neuroradiology
- Obstetrics & Gynecology
- Patient Safety & Quality Improvement
- Practice Management & Ethics
- Psychopharmacology
- Psychotic Disorders
- Cross-Specialty
- Ob/Gyn
- Psychiatry
- Radiology
- No reviews yet. Be the first to share yours.
Pricing
Free
Reported to ACCME by the provider
- Online course / module
- includes Case-based learning
- Credit · Up to 1 credit
-
ReleasedSep 22, 2025
-
Last day to claim creditSep 23, 2028 2 years left
